Biomarker Assays
Biomarker assays are laboratory methods that detect or analyse genes, proteins, or other molecules in biological samples and are fundamental tests in biotherapeutic drug monitoring, research, and development. Prolytix offers comprehensive biomarker assay development, validation, and testing services.
Biomarker assays directly assess the presence of a disease state or biological characteristic of interest. These assays are essential for monitoring drug response and supporting biotherapeutic research and development.
Prolytix offers comprehensive coagulation assays and the ability to run off‑the‑shelf MSD biomarker assays, as well as extensive experience in the development, validation, and execution of custom biomarker assays.
All biomarker testing is conducted in Prolytix’s GLP, GCLP, CLIA, and GMP bioanalytical facilities, supported by a strong FDA and client inspection track record.



